Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
March 23, 2023 07:00 ET
|
Generation Bio Co.; Moderna
Collaboration will extend the applications of each company’s platform through discovery and development of novel lipid nanoparticles using Generation Bio’s proprietary stealth cell-targeted lipid...
Generation Bio to Participate in the BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic Medicines
March 21, 2023 16:15 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference
February 27, 2023 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results
February 23, 2023 16:28 ET
|
Generation Bio Co.
— Company expects to announce data for Factor VIII expression in non-human primates in 2023 — Strong cash balance of $279.1M provides expected runway into 2025 CAMBRIDGE, Mass., Feb. 23, 2023 ...
Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023 16:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Reports Business Highlights and Third Quarter 2022 Financial Results
November 03, 2022 16:15 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit
September 22, 2022 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer
September 20, 2022 07:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results
August 04, 2022 16:15 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference
August 02, 2022 16:15 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...